Genus plc saw its London‑listed shares jump 10% to 2,892p on Friday after the animal genetics group posted a first‑half profit that exceeded forecasts and nudged up its full‑year outlook. The unaudited update projects adjusted profit before tax of roughly £50 million for the six months to 31 December, excluding a milestone payment tied to its Chinese porcine JV.

Genus confirmed that regulatory clearance from China’s State‑owned Assets Supervision and Administration Commission arrived in December, unlocking the final $7.5 million (about £5.6 million) milestone from Beijing Capital Agribusiness. Completion of the porcine joint venture and receipt of the cash are now slated for the fiscal third quarter, reinforcing the company’s China growth strategy.

Analysts now expect full‑year FY26 adjusted profit before tax, excluding the milestone, to land modestly above the top end of consensus forecasts. Investors will gauge whether the Chinese JV delivers sustainable revenue when Genus publishes its interim results on 26 February. Market eyes will also track PIC division performance and broader animal‑genetics demand.